Stock 603538 NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
12.77 CNY +0.47% Intraday chart for Ningbo Menovo Pharmaceutical Co., Ltd. +5.02% -33.21%
04-23 Menovo Pharmaceutical Unit Gets Approval to Register Vildagliptin Tablets MT
04-16 Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on July 20, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 2,936 3,696 5,555 5,312 5,494 2,724 2,724 -
Enterprise Value (EV) 1 2,936 3,696 5,555 5,312 5,494 2,724 2,724 2,724
P/E ratio 29.8 x 24 x 32.9 x 38.6 x 17.3 x 22.8 x 11.9 x 8.99 x
Yield - - - - - - - -
Capitalization / Revenue 3.46 x 3.13 x 4.65 x 4.22 x 3.77 x 1.82 x 1.56 x 1.3 x
EV / Revenue 3.46 x 3.13 x 4.65 x 4.22 x 3.77 x 1.82 x 1.56 x 1.3 x
EV / EBITDA - 14.5 x 17.2 x 18.2 x 10.7 x 8.68 x 6.16 x 5.27 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - 2.71 x 3.58 x 3.2 x 2.72 x 1.25 x 1.13 x 1.02 x
Nbr of stocks (in thousands) 208,343 209,109 209,007 208,979 213,378 213,351 213,351 -
Reference price 2 14.09 17.67 26.58 25.42 25.75 12.77 12.77 12.77
Announcement Date 09/04/19 20/04/20 19/04/21 25/04/22 03/04/23 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 849 1,180 1,194 1,258 1,457 1,495 1,745 2,100
EBITDA 1 - 254.3 323.2 291.7 514.6 314 442 517.4
EBIT 1 - 189.7 215.5 187.9 405.3 156.1 282.8 366.2
Operating Margin - 16.08% 18.06% 14.94% 27.82% 10.44% 16.21% 17.44%
Earnings before Tax (EBT) 1 - 187.2 214.7 180.3 384.2 135 264 346.1
Net income 1 - 150.9 167.4 142.5 338.7 119.6 229.3 303.4
Net margin - 12.79% 14.02% 11.33% 23.25% 8% 13.14% 14.45%
EPS 2 0.4724 0.7373 0.8089 0.6585 1.490 0.5600 1.070 1.420
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 09/04/19 20/04/20 19/04/21 25/04/22 03/04/23 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - 11.9% 11.5% 8.54% 17.6% 5.5% 9.5% 11.3%
ROA (Net income/ Total Assets) - - 5.9% - - - - -
Assets 1 - - 2,838 - - - - -
Book Value Per Share 2 - 6.520 7.420 7.940 9.450 10.20 11.30 12.60
Cash Flow per Share 2 0.2300 0.8600 1.200 1.040 1.300 0.7900 0.9600 1.300
Capex 1 - 325 311 528 568 - - -
Capex / Sales - 27.57% 26.07% 41.95% 39% - - -
Announcement Date 09/04/19 20/04/20 19/04/21 25/04/22 03/04/23 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Ningbo Menovo Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.77
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NINGBO MENOVO PHARMACEUTICAL CO., LTD. Stock Ningbo Menovo Pharmaceutical Co., Ltd.
-33.21% 376M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603538 Stock
  4. Financials Ningbo Menovo Pharmaceutical Co., Ltd.